Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Raw Materials: 2023

Historic Raw Materials for Zevra Therapeutics (ZVRA) over the last 1 years, with Dec 2023 value amounting to $2.9 million.

  • Zevra Therapeutics' Raw Materials was N/A to $4.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2023, which is N/A change from last year.
  • According to the latest figures from FY2023, Zevra Therapeutics' Raw Materials is $2.9 million.
  • Over the past 5 years, Zevra Therapeutics' Raw Materials peaked at $2.9 million during FY2023, and registered a low of $2.9 million during FY2023.
  • Its 1-year average for Raw Materials is $2.9 million, with a median of $2.9 million in 2023.